Patents Assigned to Nanomerics LTD
  • Amphiphilic carbohydrate compounds
    Patent number: 12606641
    Abstract: The present invention relates to an acetylated amphiphilic carbohydrate compound of average molecular weight 1-50 kDa which is based on a glycol chitosan, wherein the levels of acetylation can be modified. The compound can be formulated with hydrophobic compounds such as drugs. The degree of acetylation of the carbohydrate compound is optimised to maximise solubilisation of the drugs. The compound is formulated with drugs and is useful in therapy.
    Type: Grant
    Filed: May 21, 2021
    Date of Patent: April 21, 2026
    Assignee: NANOMERICS LTD
    Inventor: Ryan Mellor
  • Delivery of drugs
    Patent number: 10213474
    Abstract: The present invention relates to a composition comprising a hydrophilic drug and an amphiphilic carbohydrate compound for use in therapy wherein the composition is intranasally administered to the human or animal body. The composition can be used to treat a variety of disorders, including schizophrenia, obesity, pain and sleep disorders, psychiatric diseases, neurodegenerative conditions, brain cancers and infective diseases.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: February 26, 2019
    Assignee: Nanomerics LTD
    Inventors: Ijeoma Uchegbu, Andreas Schatzlein, Lisa Godfrey, Katerina Lalatsa, Antonio Iannitelli